COEP

JonesTrading Initiates Coverage of Coeptis Therapeutics Holdings (COEP) with Buy Recommendation

Fintel reports that on April 19, 2023, JonesTrading initiated coverage of Coeptis Therapeutics Holdings (OTC:COEP) with a Buy recommendation.

Analyst Price Forecast Suggests 302.63% Upside

As of April 6, 2023, the average one-year price target for Coeptis Therapeutics Holdings is $6.12. The forecasts range from a low of $6.06 to a high of $6.30. The average price target represents an increase of 302.63% from its latest reported closing price of $1.52.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Coeptis Therapeutics Holdings is $0MM, a decrease of �%. The projected annual non-GAAP EPS is -$0.20.

What is the Fund Sentiment?

There are 1 funds or institutions reporting positions in Coeptis Therapeutics Holdings. This is unchanged over the last quarter.

See all Coeptis Therapeutics Holdings regulatory filings.

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.